Sagimet Biosciences Inc. (SGMT) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Sagimet Biosciences Inc. (SGMT) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

SGMT Cash Flow Statement

Sagimet Biosciences Inc. (SGMT) cash flow statement — 7-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22

Cash from Operations	-10.7M	-8.61M	-11.83M	-10.18M	-9.1M	-14.54M	-11.02M	-19.57M	-5.63M	-6.21M	-7.08M	-3.88M	-5.72M	-7.08M	-7.45M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-193.95%	-	-	-
Operating CF Growth %	-17.55%	40.76%	-7.34%	47.98%	-61.54%	-134.15%	-55.64%	-404.49%	1.5%	12.37%	4.96%	-	-	-	-
Net Income	-13.95M	-10.65M	-9.57M	-12.91M	-10.39M	-18.18M	-16.2M	-14.62M	-8.12M	-6.63M	-8.15M	-6.35M	-6.79M	-6.59M	-7.2M
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	8.77M	0	0	0	0	0
Stock-Based Compensation	3.69M	1.84M	1.69M	1.69M	1.6M	1.47M	1.53M	1.55M	1.45M	759K	1.31M	1.85M	1.06M	767K	721K
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	-536K	-101K	337K	339K	-188K	2.89M	-19K	-6.29M	-442K	-8.93M	37K	32K	28K	1K	-50K
Working Capital Changes	100K	301K	-4.29M	701K	-125K	-726K	3.66M	-205K	1.48M	-181K	-280K	587K	-20K	-1.26M	-929K
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	401K	0	0	0	0	0	0	-569K	0	-782K	0	0	0	0	0
Cash from Investing	-24.02M	10.22M	14.36M	75K	-13.29M	3.41M	9.85M	624K	-75.16M	3M	-19.62M	0	12.8M	19.4M	5.44M
Capital Expenditures	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	82.95M	0	0	0	0	0	0	0
Cash from Financing	339.39M	0	0	274K	1K	0	0	0	-27K	104.85M	3.52M	87.21M	-910K	-136K	-55K
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	175M	0	0	274K	1K	0	0	0	0	105.75M	3.52M	86.16M	0	0	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	164.39M	0	0	0	0	0	0	0	-27K	-904K	0	1.05M	-910K	-136K	-55K
Net Change in Cash	304.67M	1.6M	2.52M	-9.83M	-22.39M	-11.12M	-1.17M	-18.95M	-80.82M	101.64M	-26.7M	83.33M	6.17M	12.18M	-2.07M
Free Cash Flow	-10.7M	-8.61M	-11.83M	-10.18M	-9.1M	-14.54M	-11.02M	-19.57M	-5.63M	-6.21M	-7.08M	-3.88M	-5.72M	-7.08M	-7.45M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-193.95%	-	-	-
FCF Growth %	-17.55%	40.76%	-7.34%	47.98%	-61.54%	-134.15%	-55.64%	-404.49%	1.5%	12.37%	4.96%	-	-	-	-
FCF per Share	-0.20	-0.26	-0.36	-0.31	-0.28	-0.45	-0.34	-0.61	-0.18	-0.21	-0.39	-0.21	-0.26	-0.32	-0.34
FCF Conversion (FCF/Net Income)	0.77x	0.81x	1.24x	0.79x	0.88x	0.80x	0.68x	1.34x	0.69x	0.94x	0.87x	0.61x	0.84x	1.08x	1.04x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0